Activities
The Biologics and Genetic Therapies Directorate (BGTD) is involved in a variety of activities, including the development
of new policies or regulations, and the updating of existing policies,
for example, related to biologics, radiopharmaceuticals, genetic therapies,
and the transplantation of tissues, cells, and organs. It is responsible
for a regulatory framework which ensures that safe, effective, and high
quality products or drugs, and the appropriate information about their
risks and benefits, are available to Canadians on a timely basis. These
activities performed are done so in collaboration with clients, stakeholders
and the general public.
 BI (Biologist) Development Program
|
